
Alpha Profiles · Company Profile
Arcutis Biotherapeutics, Inc.
Canonical company identity and public leadership record.
https://registry.alpha.ac/companies/arcutis-biotherapeutics-inc
- Entity
- Public listing published
- Primary listing
- NASDAQ: ARQT
- Verification
- Partially verified
- Last reviewed
- 2026-10-16T13:52:04.878381+00:00
Overview
Alpha's canonical identity and public leadership record for Arcutis Biotherapeutics, Inc..
Canonical AEGIS identity graph
Executive leadership
Current, confirmed roles are shown only when both the person Profile and supporting source record satisfy the public projection boundary. A missing role is not evidence that it does not exist.
Executive team
7 public recordsSenior Vice President and Chief Financial Officer
- State
- confirmed
- Effective
- Date not stated
- Confidence
- 94%
- Evidence
- ARQT executive roster sourceMay 3, 2026
Executive Vice President and Chief Commercial Officer
- State
- confirmed
- Effective
- Date not stated
- Confidence
- 94%
- Evidence
- ARQT executive roster sourceMay 3, 2026
Senior Vice President and Chief Financial Officer
- State
- confirmed
- Effective
- From Apr 21, 2026
- Confidence
- 94%
- Evidence
- ARQT DEF 14A executive officersApr 21, 2026
Executive Vice President and Chief Commercial Officer
- State
- confirmed
- Effective
- From Apr 21, 2026
- Confidence
- 94%
- Evidence
- ARQT DEF 14A executive officersApr 21, 2026
Executive Vice President, Chief Legal Officer and Corporate Secretary
- State
- confirmed
- Effective
- From Apr 21, 2026
- Confidence
- 94%
- Evidence
- ARQT DEF 14A executive officersApr 21, 2026
Executive Vice President and Chief Medical Officer
- State
- confirmed
- Effective
- From Apr 21, 2026
- Confidence
- 94%
- Evidence
- ARQT DEF 14A executive officersApr 21, 2026
President, Chief Executive Officer and Director
- State
- confirmed
- Effective
- From Apr 21, 2026
- Confidence
- 94%
- Evidence
- ARQT DEF 14A executive officersApr 21, 2026
Governance leadership
Boards & Committees
Board and committee assignments appear only when the canonical public projection retains a current role and supporting source. Unpublished records are not interpreted as absence.
Record as of Oct 16, 2026. Chair, executive office, Lead Independent Director and committee appointments retain their separate source roles. A complete board composition denominator and committee charters are not established by a partial roster.
Board roles
9 public records- State
- confirmed
- Effective
- From Jan 1, 2025
- Confidence
- 85%
- Evidence
- Arcutis Biotherapeutics, Inc. DEF 14A 2026-04-21Apr 21, 2026
- State
- confirmed
- Effective
- From Jan 1, 2020
- Confidence
- 85%
- Evidence
- Arcutis Biotherapeutics, Inc. DEF 14A 2026-04-21Apr 21, 2026
- State
- confirmed
- Effective
- From Jan 1, 2020
- Confidence
- 85%
- Evidence
- Arcutis Biotherapeutics, Inc. DEF 14A 2026-04-21Apr 21, 2026
- State
- confirmed
- Effective
- From Jan 1, 2021
- Confidence
- 85%
- Evidence
- Arcutis Biotherapeutics, Inc. DEF 14A 2026-04-21Apr 21, 2026
- State
- confirmed
- Effective
- From Jan 1, 2022
- Confidence
- 85%
- Evidence
- Arcutis Biotherapeutics, Inc. DEF 14A 2026-04-21Apr 21, 2026
- State
- confirmed
- Effective
- From Jan 1, 2016
- Confidence
- 85%
- Evidence
- Arcutis Biotherapeutics, Inc. DEF 14A 2026-04-21Apr 21, 2026
- State
- confirmed
- Effective
- From Jan 1, 2021
- Confidence
- 85%
- Evidence
- Arcutis Biotherapeutics, Inc. DEF 14A 2026-04-21Apr 21, 2026
- State
- confirmed
- Effective
- From Jan 1, 2020
- Confidence
- 85%
- Evidence
- Arcutis Biotherapeutics, Inc. DEF 14A 2026-04-21Apr 21, 2026
- State
- confirmed
- Effective
- From Jan 1, 2017
- Confidence
- 85%
- Evidence
- Arcutis Biotherapeutics, Inc. DEF 14A 2026-04-21Apr 21, 2026
Committees
3 public recordsMembership and chair roles are projected from current board seats. A chair is shown only when a stored chair flag says so.
Audit
- Chair
- Sue-Jean Lin
- Members
- Sue-Jean Lin (Chair); Halley E. Gilbert; Neha Krishnamohan
Compensation
- Chair
- Amit D. Munshi
- Members
- Amit D. Munshi (Chair); Keith R. Leonard, Jr.; Patrick J. Heron
Nominating and Governance
- Chair
- Terrie Curran
- Members
- Terrie Curran (Chair); Sue-Jean Lin
Source record
Alpha canonical company public projection
Supports Company identity, Published leadership, Entity status boundary
Reviewed 2026-10-16T13:52:04.878381+00:00



